Cel Sci Corporation (CVM)

[Fosco1]

What is that risk or what are those risks that require additional funds before the results are released?

Well, in my opinion, there is “Overwhelming Benefit”, “Benefit” ,“Qualitative Benefit” and “No Benefit”. Depending on the outcome of the trial, the p value, the hazard ratio and the confidence intervals, this benefit will be assessed.
In my opinion, additional funds were raised to prevent the risk of having a still beneficial drug for which the company could not fund easily the go to market. With 1 year + cash visibility, this risk is behind
Fosco